Provided by Tiger Fintech (Singapore) Pte. Ltd.

Autolus Therapeutics PLC

1.33
-0.0200-1.48%
Post-market: 1.330.00000.00%16:05 EDT
Volume:1.34M
Turnover:1.79M
Market Cap:353.95M
PE:-1.54
High:1.37
Open:1.36
Low:1.30
Close:1.35
Loading ...

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live
·
05 Dec 2024

European Equities Traded in the US as American Depositary Decline in Tuesday Trading

MT Newswires Live
·
27 Nov 2024

Stock Track | Autolus Therapeutics Soars 9.7% in Pre-Market on Analyst Upgrade and FDA Approval Prospects

Stock Track
·
18 Nov 2024

Goldman Sachs Upgrades Autolus Therapeutics to Buy From Neutral, Adjusts Price Target to $7.60 From $7

MT Newswires Live
·
18 Nov 2024

Autolus Therapeutics: FDA Approval of Aucatzyl De-Risks Platform, Significant Upside Anticipated

TIPRANKS
·
18 Nov 2024

Redburn Atlantic Upgrades Autolus Therapeutics to Buy From Neutral, Price Target is $13

MT Newswires Live
·
15 Nov 2024

Stock Track | Autolus Therapeutics Soars 5.65% Pre-Market on Groundbreaking CAR T-Cell Therapy Approval

Stock Track
·
15 Nov 2024

Stock Track | Autolus Therapeutics Surges 9.30% on Positive Developments in CAR T-Cell Therapy

Stock Track
·
15 Nov 2024

Syncona Ltd (LSE:SYNC) Half Year 2025 Earnings Call Highlights: Navigating Market Challenges ...

GuruFocus.com
·
15 Nov 2024

Autolus Therapeutics PLC (AUTL) Q3 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
13 Nov 2024

Q3 2024 Autolus Therapeutics PLC Earnings Call

Thomson Reuters StreetEvents
·
13 Nov 2024

Autolus Therapeutics PLC reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

Stock Track | Autolus Therapeutics Soars on FDA Approval of Leukemia Therapy AUCATZYL®

Stock Track
·
12 Nov 2024

Buy Recommendation for Autolus Therapeutics Driven by Favorable Safety and Efficacy of Aucatzyl

TIPRANKS
·
12 Nov 2024

Autolus Therapeutics Plc : Needham Raises Target Price to $10 From $9

THOMSON REUTERS
·
12 Nov 2024

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live
·
11 Nov 2024

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL), Molina Healthcare (MOH) and AnaptysBio (ANAB)

TIPRANKS
·
11 Nov 2024

Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham

Dow Jones
·
11 Nov 2024

Autolus Therapeutics Gets FDA Approval for Cancer Treatment

Dow Jones
·
09 Nov 2024

Autolus Therapeutics' Leukemia Treatment Receives US FDA Approval

MT Newswires Live
·
09 Nov 2024